Order from us for quality, customized work in due time of your choice.
DIRECTIONS SCREEN SHOT IN SHARED FILES!!
WEEKLY READINGS:
Goldin, D. S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing.
Chapter 9, “Stimulants/Neurodevelopmental Disorders” (pp. 178–208)
Chapter 10, “Antidementia” (pp. 208–227)
Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
Chapter 11, “Attention Deficit Hyperactivity Disorder and Its Treatment” (pp. 449–485)
Chapter 12, “Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine” (pp. 486–537)
American Academy of Pediatrics. (2019, October). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsLinks to an external site.. Pediatrics, 144(4), Article e20192528. https://doi.org/10.1542/peds.2019-2528
Drugs.comLinks to an external site.. (2023). https://www.drugs.com/
Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.
CHADD’s National Resource Center on ADHD. (2023). ADHD medications approved by the U.S. Food and Drug Administration: Stimulant medicationsLinks to an external site.. https://d393uh8gb46l22.cloudfront.net/wp-content/uploads/2020/02/ADHD-Medications-Approved-by-FDA-2.23.pdf
Note: Utilize this medication table resource to familiarize yourself with the medications aligned with the topics presented this week.
Order from us for quality, customized work in due time of your choice.